bupropion has been researched along with Stevens-Johnson Syndrome in 2 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
Stevens-Johnson Syndrome: Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report a case of erythrodermic pustular psoriasis associated with initiation of bupropion/naltrexone (Contrave®; Orexigen Therapeutics, La Jolla, CA) in a patient with no history of psoriasis." | 7.85 | Acute Generalized Erythrodermic Pustular Psoriasis Associated with Bupropion/Naltrexone (Contrave ( Cassel, KP; Eckersley, D; Moscati, RM; Singh, PA, 2017) |
| "Bupropion is a very popular medication prescribed to millions of patients globally for depression (Wellbutrin, GlaxoSmithKline, Research Triangle Park, NC) as well as an aid in smoking cessation (Zyban, GlaxoSmithKline, Research Triangle Park, NC)." | 5.36 | A case of bupropion-induced Stevens-Johnson syndrome with acute psoriatic exacerbation. ( Chon, SY; Riddel, C; Surovik, J, 2010) |
| "We report a case of erythrodermic pustular psoriasis associated with initiation of bupropion/naltrexone (Contrave®; Orexigen Therapeutics, La Jolla, CA) in a patient with no history of psoriasis." | 3.85 | Acute Generalized Erythrodermic Pustular Psoriasis Associated with Bupropion/Naltrexone (Contrave ( Cassel, KP; Eckersley, D; Moscati, RM; Singh, PA, 2017) |
| "Bupropion is a very popular medication prescribed to millions of patients globally for depression (Wellbutrin, GlaxoSmithKline, Research Triangle Park, NC) as well as an aid in smoking cessation (Zyban, GlaxoSmithKline, Research Triangle Park, NC)." | 1.36 | A case of bupropion-induced Stevens-Johnson syndrome with acute psoriatic exacerbation. ( Chon, SY; Riddel, C; Surovik, J, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Singh, PA | 1 |
| Cassel, KP | 1 |
| Moscati, RM | 1 |
| Eckersley, D | 1 |
| Surovik, J | 1 |
| Riddel, C | 1 |
| Chon, SY | 1 |
2 other studies available for bupropion and Stevens-Johnson Syndrome
| Article | Year |
|---|---|
Acute Generalized Erythrodermic Pustular Psoriasis Associated with Bupropion/Naltrexone (Contrave
Topics: Acute Kidney Injury; Biopsy; Bupropion; Cyclosporine; Dermatologic Agents; Diagnosis, Differential; | 2017 |
A case of bupropion-induced Stevens-Johnson syndrome with acute psoriatic exacerbation.
Topics: Acute Disease; Antidepressive Agents, Second-Generation; Bupropion; Depressive Disorder; Drug Erupti | 2010 |